FIELD: medicine.
SUBSTANCE: invention refers to medicine and clinical pharmacology. Disclosed is use of L-enantiomer of 2-ethyl-6-methyl-3-hydroxypyridinium L-hydroxybutanedioate as an agent exhibiting hepatoprotective, lipid-regulating, antiischemic and neurotropic activity.
EFFECT: compound provides a prolonged period of bioelectric activity of the myocardium compared to the racemate.
1 cl, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
| L-ENANTYMER OF 2-ETHYL-6-METHYL-3-HYDROXYPIRIDINIUM HYDROXYBUTANDIOATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2017 |
|
RU2663836C1 |
| NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
| SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
| NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
| USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DICHLOROACETATE, ITS STABLE CRYSTALLINE FORM AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2540070C1 |
| GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
